(200 days)
The intended use of the device YSIO X.pree is to visualize anatomical structures of human beings by converting an X-ray pattern into a visible image.
The device is a digital X-ray system to generate X-ray images from the whole body including the skull, chest, abdomen, and extremities. The acquired images support medical professionals to make diagnostic and/or therapeutic decisions.
YSIO X.pree is not for mammography examinations.
The YSIO X.pree is a radiography X-ray system. It is designed as a modular system with components such as a ceiling suspension with an X-ray tube, Bucky wall stand, Bucky table, X-ray generator, portable wireless, and fixed integrated detectors that may be combined into different configurations to meet specific customer needs.
The following modifications have been made to the cleared predicate device:
- -New Camera Model in Collimator
- -New Auto Collimation Function: Auto Long-Leg/Full-Spine
- -Two new wireless detectors
The provided text is a 510(k) summary for the YSIO X.pree X-ray system. It describes the device, its intended use, and comparisons to predicate and reference devices. However, it does not contain the detailed clinical study information typically required to directly answer all aspects of your request regarding acceptance criteria and performance metrics for an AI/CADe device.
Specifically, the document mentions:
- A "Customer Use Test (CUT)" was performed at the "Universitätsklinikum Augsburg, Germany," focusing on "System function and performance-related clinical workflow, Image quality, Ease of use, Overall performance and stability."
- "The results of the clinical test stated that the intended use of the system was met, and the clinical need covered."
- "All images acquired with the new detectors were sufficiently acceptable for radiographic usage."
This summary indicates that new features, particularly the "Auto Collimation Function: Auto Long-Leg/Full-Spine" which is AI-based (taken from the MULTIX Impact algorithm, K213700), underwent testing. However, the FDA 510(k) summary does not include the specific acceptance criteria with reported performance against those criteria, nor detailed information about the study design (sample size, ground truth establishment, expert qualifications, etc.) for the AI-based auto collimation feature. The "Customer Use Test" appears to be a general usability and performance test for the overall system and new detectors, rather than a rigorous performance study for an AI algorithm with specific quantitative metrics.
Therefore, I cannot fully complete the table and answer all questions with the provided text. I can only extract what is present.
Here's a breakdown of what can be extracted and what cannot:
1. Table of Acceptance Criteria and Reported Device Performance:
The document does not provide a table of explicit acceptance criteria for the AI-based auto collimation function with corresponding quantitative performance metrics (e.g., accuracy, precision for delimiting regions of interest). It only states that the overall system and new detectors' images were "sufficiently acceptable for radiographic usage" and that the "intended use of the system was met, and the clinical need covered."
| Acceptance Criteria | Reported Device Performance |
|---|---|
| For overall system and new detectors (from Customer Use Test): | |
| System function and performance-related clinical workflow met criteria | Intended use of the system was met, and the clinical need covered. |
| Image quality acceptable | All images acquired with the new detectors were sufficiently acceptable for radiographic usage. |
| Ease of use acceptable | Not explicitly quantified, but implied by overall "intended use met." |
| Overall performance and stability acceptable | Not explicitly quantified, but implied by overall "intended use met." |
| For AI-based Auto Collimation (Auto Long-Leg/Full-Spine): | Information Not Provided in Text |
2. Sample size used for the test set and the data provenance:
- Test set sample size for AI-based auto collimation: Not specified in the provided text.
- Data Provenance: The Customer Use Test (CUT) was performed at "Universitätsklinikum Augsburg, Germany." This suggests prospective data collection in a clinical setting in Germany for the general system and new detectors. It is not explicitly stated if the AI-based auto collimation performance was evaluated on this specific dataset, or if a separate dataset (and its provenance) was used for validating the AI. Given the AI algorithm was "taken over" from the MULTIX Impact (K213700) and that previous 510(k) for that device might contain more details.
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts:
- Not specified for any specific ground truth establishment (especially for the AI-based auto collimation). The "Customer Use Test" involved clinical evaluation, implying healthcare professionals (presumably radiologists or radiographers) were involved, but their number and specific qualifications for establishing ground truth for AI performance are not detailed.
4. Adjudication method (e.g., 2+1, 3+1, none) for the test set:
- Not specified.
5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:
- No MRMC comparative effectiveness study is described for the AI-based auto collimation. The document focuses on device safety and substantial equivalence to a predicate, not enhancement of human reader performance.
6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done:
- Not explicitly detailed. The AI auto collimation feature is integrated into the workflow, implying it assists, but a standalone technical performance study for the AI component itself is not described with quantitative results. The statement that the "Multix Impact algorithm has been taken over" suggests that its performance characteristics might have been established during the clearance of the MULTIX Impact (K213700), but those details are not in this document.
7. The type of ground truth used (expert consensus, pathology, outcomes data, etc.):
- Not specified for the AI-based auto collimation. For the general system usability and image quality, the "Customer Use Test" implies a clinical assessment, likely representing expert (clinician) judgment.
8. The sample size for the training set:
- Not specified. The document states that the AI algorithm was "taken over" from the MULTIX Impact. This implies the training was done previously for the MULTIX Impact, but the size of that training set is not provided here.
9. How the ground truth for the training set was established:
- Not specified, for the same reasons as in point 8.
{0}------------------------------------------------
Image /page/0/Picture/1 description: The image shows the logos of the Department of Health & Human Services and the Food and Drug Administration (FDA). The Department of Health & Human Services logo is on the left, and the FDA logo is on the right. The FDA logo is a blue square with the letters "FDA" in white, followed by the words "U.S. FOOD & DRUG ADMINISTRATION" in blue.
Siemens Medical Solutions USA, Inc. % Camila Rodriguez Valentin Regulatory Affairs Professional 40 Liberty Boulevard Malvern, Pennsylvania 19355
Re: K233543
Trade/Device Name: YSIO X.pree Regulation Number: 21 CFR 892.1680 Regulation Name: Stationary X-Ray System Regulatory Class: Class II Product Code: KPR Dated: November 3, 2023 Received: April 24, 2024
Dear Camila Rodriguez Valentin:
We have reviewed your section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (the Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database available at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Additional information about changes that may require a new premarket notification are provided in the FDA guidance documents entitled "Deciding When to Submit a 510(k) for a Change to an Existing Device" (https://www.fda.gov/media/99812/download) and "Deciding When to Submit a 510(k) for a Software Change to an Existing Device" (https://www.fda.gov/media/99785/download).
{1}------------------------------------------------
Your device is also subject to, among other requirements, the Quality System (QS) regulation (21 CFR Part 820), which includes, but is not limited to, 21 CFR 820.30, Design controls; 21 CFR 820.90, Nonconforming product; and 21 CFR 820.100, Corrective and preventive action. Please note that regardless of whether a change requires premarket review, the QS regulation requires device manufacturers to review and approve changes to device design and production (21 CFR 820.30 and 21 CFR 820.70) and document changes and approvals in the device master record (21 CFR 820.181).
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR Part 803) for devices or postmarketing safety reporting (21 CFR Part 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR Part 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR Parts 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
Image /page/1/Picture/6 description: The image shows the names Gabriela M. Rodal -S and Lu Jiang, Ph.D. The names are stacked on top of each other. The text is black and the background is white.
Digitally signed by for Gabriela M. Rodal -S
Lu Jiang, Ph.D. Assistant Director Diagnostic X-Ray Systems Team DHT8B: Division of Radiologic Imaging Devices and Electronic Products OHT8: Office of Radiological Health Office of Product Evaluation and Quality Center for Devices and Radiological Health
{2}------------------------------------------------
Indications for Use
Submission Number (if known)
K233543
Device Name
YSIO X.pree
Indications for Use (Describe)
The intended use of the device YSIO X.pree is to visualize anatomical structures of human beings by converting an X-ray pattern into a visible image.
The device is a digital X-ray system to generate X-ray images from the whole body including the skull, chest, abdomen, and extremities. The acquired images support medical professionals to make diagnostic and/or therapeutic decisions.
YSIO X.pree is not for mammography examinations.
Type of Use (Select one or both, as applicable)
Prescription Use (Part 21 CFR 801 Subpart D)
Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
{3}------------------------------------------------
Image /page/3/Picture/1 description: The image shows the logo for Siemens Healthineers. The word "SIEMENS" is in teal, and the word "Healthineers" is in orange. To the right of the words is a graphic of orange dots arranged in a circular pattern.
| 510(k) Summary: | YSIO X.pree |
|---|---|
| 510(k) Number: | K233543 |
| Company: | Siemens Medical Solutions USA, Inc.40 Liberty BoulevardMalvern, PA 19355 |
| Date Prepared: | May 20, 2024 |
This 510(k) summary of safety and effectiveness information is being submitted in accordance with the requirements of SMDA of 1990 and 21 CFR § 807.92.
General Information: 1.
Importer / Distributor:
Siemens Medical Solutions USA, Inc. 40 Liberty Boulevard Malvern, PA 19355 Establishment Registration Number: 2240869
Location of Manufacturing Site:
Siemens Healthineers AG Siemensstr. 1 91301 Forchheim, Germany Establishment Registration Number: 3004977335
2. Contact Person:
Camila Rodriguez Valentin Regulatory Affairs Professional Siemens Medical Solutions USA, Inc.40 Liberty Boulevard Malvern, PA 19355, US camila.rodriguezvalentin@siemens-healthineers.com
Alternate Contact Person:
Martin Rajchel Senior Regulatory Affairs Manager Siemens Medical Solutions USA, Inc.40 Liberty Boulevard Malvern, PA 19355, US martin.rajchel @ siemens-healthineers.com
{4}------------------------------------------------
Image /page/4/Picture/0 description: The image shows the Siemens Healthineers logo. The word "SIEMENS" is written in teal, and the word "Healthineers" is written in orange below it. To the right of the words is a graphic of orange dots.
3. Subject Device Name and Classification:
Trade Name: Classification Name: Classification Panel: Classification Regulation: Device Class: Product Code:
YSIO X.pree Stationary x-ray system Radiology 21 CFR §892.1680 II KPR
4. Legally Marketed Predicate Device:
| Trade Name: | YSIO X.pree |
|---|---|
| Company: | Siemens Healthineers AG |
| 510(k) Number: | K201670 |
| Classification Name: | Stationary x-ray system |
| Classification Panel: | Radiology |
| Classification Regulation: | 21 CFR §892.1680 |
| Device Class: | II |
| Product Code: | KPR |
ട. Legally Marketed Reference Device:
| Trade Name: | MULTIX Impact (VA21) |
|---|---|
| Company: | Siemens Shanghai Medical Equipment Ltd. |
| 510(k) Number: | K213700 |
| Classification Name: | Stationary x-ray system |
| Classification Panel: | Radiology |
| Classification Regulation: | 21 CFR §892.1680 |
| Device Class: | II |
| Product Code: | KPR |
{5}------------------------------------------------
Image /page/5/Picture/0 description: The image shows the logo for Siemens Healthineers. The word "SIEMENS" is written in teal, and the word "Healthineers" is written in orange below it. To the right of the text is a cluster of orange dots of varying sizes.
6. Device Description:
The YSIO X.pree is a radiography X-ray system. It is designed as a modular system with components such as a ceiling suspension with an X-ray tube, Bucky wall stand, Bucky table, X-ray generator, portable wireless, and fixed integrated detectors that may be combined into different configurations to meet specific customer needs.
The following modifications have been made to the cleared predicate device:
- -New Camera Model in Collimator
- -New Auto Collimation Function: Auto Long-Leg/Full-Spine
- -Two new wireless detectors
7. Indication for Use:
The intended use of the device YSIO X.pree is to visualize anatomical structures of human beings by converting an X-ray pattern into a visible image.
The device is a digital X-ray system to generate X-ray images from the whole body including the skull, chest, abdomen, and extremities. The acquired images support medical professionals to make diagnostic and/or therapeutic decisions.
YSIO X.pree is not for mammography examinations.
8. Technological Characteristics and Substantial Equivalence:
The subject device is the same as the predicate device. The software was updated, and two new detectors have been added. The camera model for auto collimation was changed, and the reference device Multix Impact algorithm has been taken over. The new components and features have been tested and do not raise any new concerns of safety and effectiveness. The device remains within the same classification regulation for the same technology as the predicate device. The system software design was completed in accordance with Siemens Quality Management System Design Controls. The scope of internationally recognized standards compliance remains the same.
{6}------------------------------------------------
Image /page/6/Picture/0 description: The image shows the logo for Siemens Healthineers. The word "SIEMENS" is written in teal, and the word "Healthineers" is written in orange below it. To the right of the words is a graphic of orange dots arranged in a circular pattern.
Table 8-1: Comparison of the Subject Device (YSIO X.pree VA20) to the PredicateDevice (YSIO X.pree VA10)
| Feature | Predicate deviceYSIO X.pree VA10 | Subject deviceYSIO X.preeVA20 | Comment |
|---|---|---|---|
| RegulationDescription | Stationary X-Ray System | Stationary X-Ray System | Same |
| Regulation Number | 892.1680 | 892.1680 | Same |
| Classification ProductCode | KPR | KPR | Same |
| Indications for use | YSIO X.pree is a deviceintended to visualizeanatomical structures byconverting an X-ray patterninto a visible image.YSIO X.pree enablesradiographic exposures ofthe whole body and may beused on pediatric, adult andbariatric patients. It can alsobe used for emergencyapplications.YSIO X.pree is not formammographyexaminations. | The intended use of the deviceYSIO X.pree is to visualizeanatomical structures ofhumanbeings by converting an X-raypattern into a visible image.The device is a digital X-raysystem to generate X-rayimages from the whole bodyincluding the skull, chest,abdomen, and extremities.The acquired images supportmedical professionals to makediagnostic and/or therapeuticdecisions.YSIO X.pree is not formammography examinations. | Similar |
| X-Ray | |||
| Generator | Polydoros R8065/80 kW | Polydoros R8065/80 kW | Same |
| X-Ray tube | OPTITOP150/40/80/HC-100 | OPTITOP150/40/80/HC-100 | Same |
| X-ray techniques | Radiography | Radiography | Same |
| Collimator | Digital MultileafCollimator N | Digital MultileafCollimator N | Same |
| Air kerma | Kerma X | Kerma X | Same |
| CARE | CombinedApplications toReduce Exposure | CombinedApplications toReduce Exposure | Same |
| Touch user interfaceon tube suspensionDigital Imaging | touchscreen in landscapeformat | touchscreen in landscapeformat | Same |
| Feature | Predicate deviceYSIO X.pree VA10 | Subject deviceYSIO X.preeVA20 | Comment |
| Fixed detector fortable and wall stand | Trixell pixium 4343RC"Max Static" | Trixell pixium 4343RC"Max Static" | Same |
| Trixell pixium3543EZh, "MAX wi-D" | Trixell pixium3543EZh, "MAX wi-D" | Same | |
| Large mobile detectors | N/A | Trixell pixium 3543EZ3"X.wi-D 35" | New for YSIOX.pree VA20 |
| N/A | Trixell pixium 4343EZ3"X.wi-D 43" | New for YSIOX.pree VA20 | |
| Small mobile detector | Trixell pixium 2430EZ"MAX mini" | Trixell pixium 2430EZ "MAXmini" | Same |
| syngo XR | syngo XR | Same | |
| Operating system Windows10 | Operating system Windows10 | Same | |
| Operated via touch screen | Operated via touch screen | Same | |
| Digital imagingsystem | Image processing withmyExam IQ | Image processing withmyExam IQ | Same |
| AI-based Auto Cropping | AI-based Auto Cropping | Same | |
| Acquisition and Imageprocessing parametersselected via clinicalprotocols | Acquisition and Imageprocessing parametersselected via clinical protocols | Same | |
| Other Features and Components | |||
| Patient Table | Table with fixed detectorand table with bucky | Table with fixed detector andtable with bucky | Same |
| Standard tabletop and flattabletop | Standard tabletop and flattabletop | Same | |
| Wall stand | Wall stand with fixeddetector and wall stand withbucky | Wall stand with fixed detectorand wall stand with bucky | Same |
| Camera | Live camera for patientpositioning and collimation | Live camera for patientpositioning and collimation | SimilarNew CameraModel, samefunctionality |
| Auto Thorax Collimation | Auto Thorax Collimation | Different. | |
| AI based Automaticcollimation | N/A | Auto Long-Leg/Full-Spinecollimation | Changed to newalgorithm, AutoLong-Leg/Full-Spine collimationadded |
| Cropping | AI-based auto cropping | AI-based auto cropping | Same |
| Wireless RemoteControl | Yes, same type | Yes, same type | Same |
| Feature | Predicate deviceMULTIX Impact | Subject deviceYSIO X.pree VA20 | Comment |
| Camera | Live camera for patientpositioning and collimation | Live camera for patientpositioning and collimation | SameThe camera, usedfor MULTIXImpact, is now usedfor YSIO X.preeVA20 |
| AI based Automatic collimation | Auto Thorax, Auto Long-Leg/Full-Spine collimation | Auto Thorax, Auto Long-Leg/Full-Spine collimation | SameThe algorithm, usedin MULTIX Impact,is also used forYSIO X.pree VA20 |
40 Liberty Boulevard
Malvern, PA 19355
USA
{7}------------------------------------------------
Image /page/7/Picture/0 description: The image shows the logo for Siemens Healthineers. The word "SIEMENS" is written in teal, and the word "Healthineers" is written in orange. To the right of the words is a graphic of orange dots.
40 Liberty Boulevard
Malvern, PA 19355
USA
Tel.: +1-888-826-9702
usa.siemens.com/healthineers
{8}------------------------------------------------
Image /page/8/Picture/0 description: The image shows the Siemens Healthineers logo. The word "SIEMENS" is in teal, and the word "Healthineers" is in orange. To the right of the words is a graphic of orange dots in a circular pattern.
Table 8-2: Comparison of the Subject Device (YSIO X.pree VA20) to the Reference Device (Multix Impact) – AI based Automatic Collimation
Summary of Non-Clinical Tests: 9.
The YSIO X.pree was tested and complies with the voluntary standards listed in the table below:
| Table 9: Non-clinical performance testing | |||
|---|---|---|---|
| ------------------------------------------- | -- | -- | -- |
| Standards DevelopmentOrganization and ReferenceNumber | Title of Standard |
|---|---|
| ANSI AAMI60601-1, 2012 Ed. 3.1 | Medical Electrical Equipment - Part 1: GeneralRequirements for Safety |
| IEC 60601-1-2 2014 Ed 4.1 | Medical Electrical Equipment - Part 1-2: General requirements forbasic safety and essential performance - Collateral Standard:Electromagnetic disturbances - Requirements and tests |
| IEC 60601-1-3:Edition 2.1, 2013 | Medical electrical equipment - Part 1-3: General requirements forbasic safety and essential performance - Collateral Standard:Radiation protection in diagnostic X-ray equipment |
| IEC 60601-2-28, 2017 | Medical electrical equipment - Part 2-28: Particular requirementsfor the basic safety and essential performance of X-ray tubeassemblies for medical diagnosis |
{9}------------------------------------------------
Image /page/9/Picture/0 description: The image contains the logo for Siemens Healthineers. The word "SIEMENS" is written in teal, and the word "Healthineers" is written in orange below it. To the right of the word "Healthineers" is a graphic of orange dots.
| IEC 60601-2-542018, Edition 1.2 | Medical electrical equipment - Part 2-54: Particular requirementsfor the basic safety and essential performance of X-ray equipmentfor radiography and radioscopy |
|---|---|
| IEC 60601-1-62020 Ed 3.2 | Medical electrical equipment - Part 1-6: General requirements forbasic safety and essential performance - Collateral standard:Usability |
| IEC 62366-1 2020 Ed 1.1 | Medical devices – Application of usability engineering tomedicaldevices |
| ISO 14971: 2019 | Medical devices - application of risk management tomedicaldevices |
| IEC 62304 2015, Ed.1.1 | Medical device software - Software life cycle processes |
| IEC 61910-1: 2014, Ed 1.0 | Medical electrical equipment - Radiation dose documentation -Part 1: Radiation dose structured reports for radiography andradioscopy |
| NEMA PS 3.1 - 3.20 2021 | Digital Imaging and Communications in Medicine(DICOM) Set |
| ISO EN ISO 10993-1Fifth edition 2018 | Biological evaluation of medical devices - Part1: Evaluation andtesting within a risk management process |
The following quality assurance measures were applied to the development of the system:
- Risk Analysis
- Requirement Specification Reviews
- Design Reviews
- Integration testing (System verification and validation)
{10}------------------------------------------------
Image /page/10/Picture/0 description: The image contains the logos for Siemens and Healthineers. The word "SIEMENS" is in teal, and the word "Healthineers" is in orange. To the right of the words is a graphic of orange dots arranged in a circular pattern.
10. Summary of Clinical Tests:
A Customer Use Test (CUT) was performed at the "Universitätsklinikum Augsburg, Germany, to ensure the acceptance of the design and to gather feedback on the usability of the device on the clinical environment.
The focus of the test was:
- System function and performance-related clinical workflow
- Image quality
- Ease of use
- Overall performance and stability
The results of the clinical test stated that the intended use of the system was met, and the clinical need covered.
General Safety and Effectiveness Concerns: 11.
The Instructions for Use (IFU) are included within the device labeling, and the information provided enables the user to operate the device safely and effectively. Several safety features including visual and audible warnings are incorporated into the system design. In addition, the device is continually monitored, and if an error occurs, the system functions will be blocked, and an error message will be displayed.
Furthermore, the operators are health care professionals familiar with and responsible for the X-ray examinations to be performed. To minimize electrical, mechanical and radiation hazards, Siemens adheres to recognized and established industry practice, and all equipment is subject to final performance testing.
12. Conclusion as to Substantial Equivalence:
The YSIO X.pree, that is the subject of this 510(k), is the same as the predicate device. The operating environment is the same and the changes do not affectiveness. Siemens concludes, according to this submission material and the documentation provided, that the YSIO X.pree is substantially equivalent to the predicate device and reference device.
The newly introduced wireless detectors (X.wi-D35 and X.wi D43) were tested during a Clinical Use Test (CUT) at University Hospital Augsburg in Germany according to "Guidance of Submission of 510(k)s for Solid State X-ray Imaging Devices" Document issued on: September 1, 2016. All images acquired with the new detectors were sufficiently acceptable for radiographic usage. Together with the non-clinical testing, it has met the objective of demonstrating substantial equivalence when comparing the Siemens YSIO X.pree VA20 to the Siemens YSIO X.pree VA10 detectors.
{11}------------------------------------------------
Image /page/11/Picture/0 description: The image shows the logo for Siemens Healthineers. The word "SIEMENS" is written in teal, and the word "Healthineers" is written in orange. To the right of the words is a graphic of orange dots.
13. Guidance documents
The following FDA guidance documents were utilized in this Premarket Notification:
Provision for Alternate Measure of the Computed Tomography Dose Index (CTDI) to Assure Compliance with the Dose Information Requirements of the Federal Performance Standard for Computed Tomography Document issued on October 20, 2006
Cybersecurity in Medical Devices: Quality System Considerations and Content of Premarket Submission - Guidance for Industry and Food and Drug Administration Staff Document Issued on September 27, 2023
Information to Support a Claim of Electromagnetic Compatibility(EMC) of Electrically- Powered Medical Devices - Guidance for Industry and Food and Drug Administration Staff Document issued on July 11, 2016
Content of Premarket Submissions for Device Software Functions - Guidance for Industry and FDA Staff Document issued on June 14, 2023
Appropriate Use of Voluntary Consensus Standards in Premarket Submissions for Medical Devices - Guidance for Industry and Food and Drug Administration Staff Document issued on September 14, 2018.
The 510(k) Program: Evaluation Substantial Equivalent in Premarket Notifications 510(k) - Guidance for Industry and Food and Drug Administration Staff Document issued on July 28, 2014.
Pediatric Information for X-ray Imaging Device Premarket Notifications - Guidance for Industry and Food and Drug Administration Staff Document issued on November 28, 2017
Guidance for the Submission of 510(k)s for Solid State X-ray Imaging Devices - Guidance for Industry and Food and Drug Administration Staff Document issued on September 1, 2016
Radio Frequency Wireless Technology in Medical Devices - Guidance for Industry and Food and Drug Administration Staff Document issue on August 13, 2013
§ 892.1680 Stationary x-ray system.
(a)
Identification. A stationary x-ray system is a permanently installed diagnostic system intended to generate and control x-rays for examination of various anatomical regions. This generic type of device may include signal analysis and display equipment, patient and equipment supports, component parts, and accessories.(b)
Classification. Class II (special controls). A radiographic contrast tray or radiology diagnostic kit intended for use with a stationary x-ray system only is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 892.9.